Series A startup

Who invested in Mnemo Therapeutics

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$90Mraised across 1 round since 2021, from 1 source

Latest round
Series A, $90MJun 2021
Investors
4
See who backed them

The rounds

  1. Jun 2021

Everyone who backed them

Sofinnova PartnersVC firm1round
Redmile GroupVC firm1round
Casdin CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Mnemo Therapeutics

Who invested in Mnemo Therapeutics?

Mnemo Therapeutics's investors include Sofinnova Partners, Redmile Group, Alexandria Venture Investments and Casdin Capital.

How much has Mnemo Therapeutics raised?

Mnemo Therapeutics has raised $90M across 1 round since 2021.

When did Mnemo Therapeutics last raise?

Mnemo Therapeutics's most recent round was a Series A of $90M in Jun 2021.

What was Mnemo Therapeutics's biggest round?

Its most recent round, $90M in Jun 2021, is also its largest on record.

Who backed Mnemo Therapeutics first?

Mnemo Therapeutics's first round on record, in Jun 2021, was backed by Sofinnova Partners, Redmile Group and Alexandria Venture Investments and 1 others.

What stage is Mnemo Therapeutics at?

Mnemo Therapeutics's latest named round is a Series A, in Jun 2021.

Companies like Mnemo Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.